Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)
Status:
Completed
Trial end date:
2019-03-11
Target enrollment:
Participant gender:
Summary
Inhaled corticosteroids (ICS) are considered first-line treatment for persistent asthma, yet
little is known about the genetic factors that influence response to this therapy. This study
seeks to quantify response to ICS therapy in African American and white patients, as well as
look for genetic markers that predict treatment response.